Lao MR1, Calhoun BC, Bracero LA, Wang Y, Seybold DJ, Broce M, Hatjis CG. (2009). “The ability of the quadruple test to predict adverse perinatal outcomes in a high-risk obstetric population”. J. Med. Screen.16 (2): 55-59. doi:10.1258/jms.2009.009017. PMID19564516.
Ball RH, Caughey AB, Malone FD, et al. (2007). “First- and second-trimester evaluation of risk for Down syndrome”. Obstet Gynecol110 (1): 10–7. doi:10.1097/01.AOG.0000263470.89007.e3. PMID17601890.
Wald NJ, Morris JK, Ibison J, Wu T, George LM (2006). “Screening in early pregnancy for pre-eclampsia using Down syndrome quadruple test markers”. Prenat. Diagn.26 (6): 559–64. doi:10.1002/pd.1459. PMID16700087.
Lao MR1, Calhoun BC, Bracero LA, Wang Y, Seybold DJ, Broce M, Hatjis CG. (2009). “The ability of the quadruple test to predict adverse perinatal outcomes in a high-risk obstetric population”. J. Med. Screen.16 (2): 55-59. doi:10.1258/jms.2009.009017. PMID19564516.
Ball RH, Caughey AB, Malone FD, et al. (2007). “First- and second-trimester evaluation of risk for Down syndrome”. Obstet Gynecol110 (1): 10–7. doi:10.1097/01.AOG.0000263470.89007.e3. PMID17601890.
Lamlertkittikul S, Chandeying V (2007). “Experience on triple markers serum screening for Down syndrome fetus in Hat Yai, Regional Hospital”. J Med Assoc Thai90 (10): 1970–6. PMID18041410.
Wald NJ, Morris JK, Ibison J, Wu T, George LM (2006). “Screening in early pregnancy for pre-eclampsia using Down syndrome quadruple test markers”. Prenat. Diagn.26 (6): 559–64. doi:10.1002/pd.1459. PMID16700087.